184 related articles for article (PubMed ID: 25989920)
21. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06).
Tarride JE; Lim ME; Bowen JM; McCarron CE; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
Int J Technol Assess Health Care; 2009 Apr; 25(2):214-21. PubMed ID: 19331712
[TBL] [Abstract][Full Text] [Related]
22. Early technology assessment of new medical devices.
Pietzsch JB; Paté-Cornell ME
Int J Technol Assess Health Care; 2008; 24(1):36-44. PubMed ID: 18218167
[TBL] [Abstract][Full Text] [Related]
23. The high cost of foreign sourcing.
Harding M
Hosp Mater Manage Q; 1997 Aug; 19(1):73-6. PubMed ID: 10168478
[TBL] [Abstract][Full Text] [Related]
24. Quantifying opportunities for hospital cost control: medical device purchasing and patient discharge planning.
Robinson JC; Brown TT
Am J Manag Care; 2014 Sep; 20(9):e418-24. PubMed ID: 25364878
[TBL] [Abstract][Full Text] [Related]
25. Organisational impact: Definition and assessment methods for medical devices.
Roussel C; Carbonneil C; Audry A;
Therapie; 2016 Feb; 71(1):69-96. PubMed ID: 27080633
[TBL] [Abstract][Full Text] [Related]
26. Five pillars for societal perspective.
Drost RMWA; Paulus ATG; Evers SMAA
Int J Technol Assess Health Care; 2020 Apr; 36(2):72-74. PubMed ID: 32000868
[TBL] [Abstract][Full Text] [Related]
27. Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.
Ghabri S; Hamers FF; Josselin JM
Pharmacoeconomics; 2016 Jun; 34(6):617-24. PubMed ID: 26829942
[TBL] [Abstract][Full Text] [Related]
28. The consequence of secret prices: the politics of physician preference items.
Lerner JC; Fox DM; Nelson T; Reiss JB
Health Aff (Millwood); 2008; 27(6):1560-5. PubMed ID: 18997212
[TBL] [Abstract][Full Text] [Related]
29. Clinical studies of innovative medical devices: what level of evidence for hospital-based health technology assessment?
Boudard A; Martelli N; Prognon P; Pineau J
J Eval Clin Pract; 2013 Aug; 19(4):697-702. PubMed ID: 23510375
[TBL] [Abstract][Full Text] [Related]
30. The economic evaluation of medical devices: challenges ahead.
Kirisits A; Redekop WK
Appl Health Econ Health Policy; 2013 Feb; 11(1):15-26. PubMed ID: 23329383
[TBL] [Abstract][Full Text] [Related]
31. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
Shiroiwa T; Fukuda T; Ikeda S; Takura T
Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty.
Martelli N; Devaux C; van den Brink H; Pineau J; Prognon P; Borget I
PLoS One; 2015; 10(12):e0144892. PubMed ID: 26661078
[TBL] [Abstract][Full Text] [Related]
33. Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value.
Sorenson C; Drummond M; Burns LR
Health Aff (Millwood); 2013 Apr; 32(4):788-96. PubMed ID: 23569060
[TBL] [Abstract][Full Text] [Related]
34. [Assessment of benefit and efficiency of innovative medical devices].
Perleth M; Lühmann D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):825-30. PubMed ID: 20700782
[TBL] [Abstract][Full Text] [Related]
35. Addressing the need for economic evaluation of cardiovascular medical devices in India.
Masurkar PP
Curr Probl Cardiol; 2024 Aug; 49(8):102677. PubMed ID: 38795804
[TBL] [Abstract][Full Text] [Related]
36. Impact of the 1997 Canadian guidelines on the conduct of Canadian-based economic evaluations in the published literature.
Lim ME; Bowen JM; O'Reilly D; McCarron CE; Blackhouse G; Hopkins R; Goeree R; Tarride JE
Value Health; 2010; 13(2):328-34. PubMed ID: 19804434
[TBL] [Abstract][Full Text] [Related]
37. Health technology assessment for medical devices in Europe. What must be considered.
Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluation approaches for new technology.
Papatheofanis FJ
IEEE Eng Med Biol Mag; 2003; 22(3):16-7. PubMed ID: 12845811
[No Abstract] [Full Text] [Related]
39. Dynamics of device innovation: implications for assessing value.
Gelijns AC; Russo MJ; Hong KN; Brown LD; Ascheim DD; Moskowitz AJ
Int J Technol Assess Health Care; 2013 Oct; 29(4):365-73. PubMed ID: 24290326
[TBL] [Abstract][Full Text] [Related]
40. Medical devices early assessment methods: systematic literature review.
Markiewicz K; van Til JA; IJzerman MJ
Int J Technol Assess Health Care; 2014 Apr; 30(2):137-46. PubMed ID: 24805836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
